Clinic
Oda Primary Health Care Network, INC.
Oda Primary Health Care Network, INC. was paid $36.91M by Medicaid between Sep 2019 and Dec 2024, across 133 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 36% of everything it billed.
33Billing provider infoODA PRIMARY HEALTH CARE NETWORK, INC.
BROOKLYN, NY 11249
BROOKLYN, NY 11249
33aNPI1184186496assigned 04/04/2019
33bProvider typeFederally Qualified Health Center (FQHC)
28Total paid$36.91M
24GClaims1,208,128
24DCodes billed133
24AFirst – last monthSep 2019 – Dec 2024
Compared with peers
Next to other Federally Qualified Health Center (FQHC) providers in New York
Rank by total paid#10 of 158
Median peer was paid$1.73M
This provider vs. median21×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 64,827 | $1.98M | |
| 2020 | 245,852 | $10.25M | |
| 2021 | 324,396 | $14.53M | |
| 2022 | 211,196 | $5.79M | |
| 2023 | 202,656 | $2.94M | |
| 2024incomplete | 159,201 | $1.42M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 36% | 338,137 | 237,957 | $13.36M |
| 94760 | 16% | 219,438 | 111,683 | $5.99M | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 6.7% | 116,281 | 83,252 | $2.48M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 6.1% | 53,902 | 34,442 | $2.25M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.2% | 33,172 | 24,536 | $1.57M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 4.1% | 43,280 | 23,030 | $1.53M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.7% | 22,435 | 12,355 | $993K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.5% | 28,187 | 17,854 | $922K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 2.4% | 22,126 | 12,814 | $872K |
| 17110 | 2.3% | 8,153 | 6,999 | $842K | |
| G0511 | Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month | 1.8% | 8,337 | 4,264 | $672K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.4% | 16,613 | 10,810 | $524K |
121 more codes
| 36415 | Collection of venous blood by venipuncture | <1% | 39,056 | $367K |
| 99401 | <1% | 11,198 | $331K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 10,431 | $259K |
| D1110 | Prophylaxis - adult | <1% | 5,558 | $205K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 5,552 | $193K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 9,101 | $188K |
| D0120 | Dental checkup, returning patient | <1% | 8,296 | $179K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 28,327 | $173K |
| 99173 | <1% | 7,760 | $161K | |
| D0220 | Intraoral - periapical first radiographic image | <1% | 14,894 | $152K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 19,542 | $151K |
| 99381 | <1% | 1,721 | $140K | |
| 85018 | <1% | 14,711 | $138K | |
| 81000 | <1% | 8,597 | $132K | |
| 99490 | Ccm add 20min | <1% | 1,563 | $128K |
| D0140 | Limited oral evaluation - problem focused | <1% | 10,684 | $111K |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | <1% | 2,017 | $101K |
| D1120 | Dental cleaning, child | <1% | 3,013 | $98K |
| 83655 | <1% | 5,072 | $96K | |
| 11730 | <1% | 1,713 | $95K | |
| G0467 | Community health center visit, returning patient | <1% | 3,561 | $95K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 4,765 | $85K |
| D0274 | Bitewings - four radiographic images | <1% | 4,314 | $84K |
| 11721 | <1% | 1,809 | $77K | |
| 36416 | <1% | 5,404 | $76K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 2,034 | $73K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 955 | $72K |
| D2751 | Crown - porcelain fused to predominantly base metal | <1% | 194 | $70K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 1,339 | $68K |
| D0270 | <1% | 5,996 | $63K | |
| D0272 | Bitewings - two radiographic images | <1% | 3,802 | $48K |
| 69210 | <1% | 2,030 | $48K | |
| 10060 | <1% | 691 | $44K | |
| 11720 | <1% | 883 | $37K | |
| 92551 | <1% | 3,388 | $33K | |
| D2930 | Prefabricated stainless steel crown - primary tooth | <1% | 458 | $32K |
| D1208 | Topical application of fluoride, excluding varnish | <1% | 2,866 | $32K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 100 | $29K |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 840 | $28K |
| 90723 | <1% | 2,521 | $26K | |
| D2150 | Silver amalgam - two surfaces, primary or permanent | <1% | 555 | $26K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 4,197 | $25K |
| 17111 | <1% | 188 | $24K | |
| D3220 | Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction | <1% | 432 | $23K |
| 0012A | <1% | 721 | $22K | |
| D1206 | Topical application of fluoride varnish | <1% | 779 | $20K |
| 93000 | <1% | 1,085 | $19K | |
| D3320 | <1% | 106 | $17K | |
| 0011A | <1% | 720 | $17K | |
| D0230 | Intraoral - periapical each additional radiographic image | <1% | 3,231 | $16K |
| D1351 | Sealant - per tooth | <1% | 420 | $15K |
| J2916 | Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | <1% | 2,863 | $14K |
| 90686 | <1% | 2,660 | $12K | |
| 90461 | <1% | 7,617 | $11K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 419 | $10K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,043 | $10K |
| 90677 | <1% | 704 | $9K | |
| D9110 | <1% | 507 | $8K | |
| D0150 | Comprehensive oral evaluation - new or established patient | <1% | 372 | $8K |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 214 | $7K |
| 12001 | <1% | 83 | $6K | |
| 0064A | <1% | 141 | $5K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 90 | $5K |
| 11900 | <1% | 95 | $5K | |
| 0001A | <1% | 124 | $5K | |
| D2140 | <1% | 157 | $4K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 101 | $4K |
| M0245 | Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring | <1% | 12 | $3K |
| D2393 | Resin-based composite - three surfaces, posterior, primary or permanent | <1% | 50 | $3K |
| 0071A | <1% | 75 | $3K | |
| 99441 | <1% | 94 | $3K | |
| 11102 | <1% | 25 | $2K | |
| 0072A | <1% | 66 | $2K | |
| 0002A | <1% | 59 | $2K | |
| D2954 | <1% | 25 | $2K | |
| D0210 | Intraoral - complete series of radiographic images | <1% | 245 | $2K |
| 90670 | <1% | 1,290 | $2K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 34 | $2K |
| 90648 | <1% | 728 | $1K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 171 | $1K |
| G0466 | Community health center visit, new patient | <1% | 116 | $1K |
| 73630 | <1% | 148 | $1K | |
| 90710 | <1% | 500 | $1K | |
| 99443 | <1% | 28 | $1K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 486 | $1K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 21 | $1K |
| 90716 | <1% | 285 | $975.66 | |
| 90682 | <1% | 16 | $900.00 | |
| 99000 | <1% | 2,955 | $850.88 | |
| 0031A | <1% | 24 | $694.84 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 329 | $679.76 |
| 90715 | <1% | 218 | $616.33 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 50 | $572.56 |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 48 | $569.22 |
| 90734 | <1% | 54 | $549.36 | |
| 73140 | <1% | 29 | $454.08 | |
| D1354 | <1% | 27 | $450.00 | |
| 86580 | <1% | 26 | $403.04 | |
| 90656 | <1% | 100 | $150.06 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 100 | $140.09 |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 28 | $122.83 |
| 81025 | <1% | 65 | $40.98 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 122 | $24.47 |
| 85048 | <1% | 32 | $1.14 | |
| 91307 | <1% | 121 | $0.41 | |
| 91306 | <1% | 119 | $0.39 | |
| 91300 | <1% | 198 | $0.25 | |
| 91301 | <1% | 923 | $0.12 | |
| M0239 | Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring | <1% | 19 | $0.11 |
| 91303 | <1% | 43 | $0.01 | |
| 90619 | 0% | 297 | $0.00 | |
| 90697 | 0% | 394 | $0.00 | |
| 90696 | 0% | 314 | $0.00 | |
| 90651 | 0% | 15 | $0.00 | |
| 90660 | 0% | 13 | $0.00 | |
| 90707 | 0% | 242 | $0.00 | |
| 73130 | 0% | 17 | $0.00 | |
| 90700 | 0% | 181 | $0.00 | |
| Q0239 | Injection, bamlanivimab-xxxx, 700 mg | 0% | 19 | $0.00 |
| 90672 | 0% | 71 | $0.00 | |
| 90661 | 0% | 20 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTEITELBAUM, ROSE (CFO)
Parent organizationODA PRIMARY HEALTH CARE NETWORK, INC.
| Provider | Location | Paid |
|---|---|---|
| Oda Primary Health Care Network, INC. | Brooklyn, NY | $6.88M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.